Epidemiologic and Clinical Outcomes of Pediatric Renal Tumors in Korea: A Retrospective Analysis of The Korean Pediatric Hematology and Oncology Group (KPHOG) Data
Kyung-Nam Koh,Jung Woo Han,Hyoung Soo Choi,Hyoung Jin Kang,Ji Won Lee,Keon Hee Yoo,Ki Woong Sung,Hong Hoe Koo,Kyung Taek Hong,Jung Yoon Choi,Sung Han Kang,Hyery Kim,Ho Joon Im,Seung Min Hahn,Chuhl Joo Lyu,Hee-Jo Baek,Hoon Kook,Kyung Mi Park,Eu Jeen Yang,Young Tak Lim,Seongkoo Kim,Jae Wook Lee,Nack-Gyun Chung,Bin Cho,Meerim Park,Hyeon Jin Park,Byung-Kiu Park,Jun Ah Lee,Jun Eun Park,Soon Ki Kim,Ji Yoon Kim,Hyo Sun Kim,Youngeun Ma,Kyung Duk Park,Sang Kyu Park,Eun Sil Park,Ye Jee Shim,Eun Sun Yoo,Kyung Ha Ryu,Jae Won Yoo,Yeon Jung Lim,Hoi Soo Yoon,Mee Jeong Lee,Jae Min Lee,In-Sang Jeon,Hye Lim Jung,Hee Won Chueh,Seunghyun Won,Korean Pediatric Hematology and Oncology Group (KPHOG)
DOI: https://doi.org/10.4143/crt.2022.073
Abstract:Purpose: Renal tumors account for approximately 7% of all childhood cancers. These include Wilms tumor (WT), clear cell sarcoma of the kidney (CCSK), malignant rhabdoid tumor of the kidney (MRTK), renal cell carcinoma (RCC), congenital mesoblastic nephroma (CMN) and other rare tumors. We investigated the epidemiology of pediatric renal tumors in Korea. Materials and methods: From January 2001 to December 2015, data of pediatric patients (0-18 years) newly-diagnosed with renal tumors at 26 hospitals were retrospectively analyzed. Results: Among 439 patients (male, 240), the most common tumor was WT (n=342, 77.9%), followed by RCC (n=36, 8.2%), CCSK (n=24, 5.5%), MRTK (n=16, 3.6%), CMN (n=12, 2.7%), and others (n=9, 2.1%). Median age at diagnosis was 27.1 months (range 0-225.5) and median follow-up duration was 88.5 months (range 0-211.6). Overall, 32 patients died, of whom 17, 11, 1, and 3 died of relapse, progressive disease, second malignant neoplasm, and treatment-related mortality. Five-year overall survival and event free survival were 97.2% and 84.8% in WT, 90.6% and 82.1% in RCC, 81.1% and 63.6% in CCSK, 60.3% and 56.2% in MRTK, and 100% and 91.7% in CMN, respectively (p < 0.001). Conclusion: The pediatric renal tumor types in Korea are similar to those previously reported in other countries. WT accounted for a large proportion and survival was excellent. Non-Wilms renal tumors included a variety of tumors and showed inferior outcome, especially MRTK. Further efforts are necessary to optimize the treatment and analyze the genetic characteristics of pediatric renal tumors in Korea.